Corrigendum to "Interleukin-40 is a promising biomarker associated with type 2 diabetes mellitus risk" [Immunology Letters 254 (2023) 1-5].

Immunol Lett

Tropical-Biological Research Unit, College of Science, University of Baghdad, Baghdad, Iraq. Electronic address:

Published: November 2023

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imlet.2023.07.002DOI Listing

Publication Analysis

Top Keywords

corrigendum "interleukin-40
4
"interleukin-40 promising
4
promising biomarker
4
biomarker associated
4
associated type
4
type diabetes
4
diabetes mellitus
4
mellitus risk"
4
risk" [immunology
4
[immunology letters
4

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!